Allergic Rhinitis, Atopic Dermatitis, Bronchial Asthma
Pediatrics · Topic 28
Source: NMC CBME Curriculum 2024 · Volume II · Pediatrics · Topic 28 · combined PDF page 348
Practice questions
- In the Fukui school survey, what was the reported current prevalence of house-dust-mite allergic rhinitis among analyzed elementary-school children?
- A trainee quotes the Fukui study's 18.8% AR-HDM figure as the expected prevalence in all children worldwide. Which interpretation is most appropriate?
- Among children with AR-HDM in the Fukui survey, what did the 68.3% figure represent?
- A 4-year-old has persistent nasal symptoms and a history of atopic dermatitis. Which inference is best supported by the Fukui survey?
- In the Fukui survey, what proportion of children with AR-HDM had received some form of treatment?
- Which statement correctly interprets the 4.2% allergen-immunotherapy figure in the Fukui survey?
- Which set of characteristics was reported as associated with AR-HDM onset in the Fukui survey's regression analysis?
- A student concludes that atopic dermatitis causes AR-HDM because the Fukui study found an association between them. What is the key problem with this conclusion?
- The Fukui survey invited 41,000 elementary-school students, and 17,974 subjects were analyzed. Which denominator is relevant to the reported 18.8% prevalence estimate?
- Which conclusion is justified by the Fukui survey's design and findings?
- In the pediatric house-dust-mite SCIT cohort, what was the overall reported incidence of local adverse reactions per injection?
- What was the overall systemic adverse-reaction incidence per injection in the pediatric house-dust-mite SCIT cohort?
- A report states that systemic adverse reactions occurred in 2.17% of injections during pediatric SCIT. Which interpretation is correct?
- In the SCIT disease-type comparison, which group had significantly higher per-injection rates of grade I and grade II systemic reactions than both the AR-alone and AR-plus-atopic-dermatitis groups?
- A child with AR and comorbid asthma is being considered for house-dust-mite SCIT. Which interpretation best matches the supplied cohort evidence?
- In the SCIT cohort, how did the reported local adverse-reaction rate per injection compare between maintenance and initiation phases?
- Which phase comparison was reported for systemic adverse reactions during pediatric SCIT?
- Which statement most accurately summarizes the SCIT phase findings?
- Which immunologic measurements were reported as higher in the systemic adverse-reaction group than in the group without systemic reactions?
- A child has a high house-dust-mite-specific IgE result before SCIT. What can be concluded from the supplied SCIT cohort evidence?
- How many injections were analyzed in the pediatric SCIT cohort, and how many children were enrolled overall?
- The disease-type analysis of the SCIT cohort included 119 children. Which distribution was reported?
- Which conclusion about pediatric SCIT safety is most defensible from the supplied retrospective cohort?
- How was the pediatric olfaction study organized?
- Which olfactory finding was reported in children with atopic dermatitis in the prospective pediatric study?
- Which statement best describes the allergic-rhinitis group's olfactory findings?
- A reader sees the report of more hyposmia in the allergic-rhinitis group and states that its mean threshold score was significantly lower than controls. Which correction is needed?
- Which statement about the bronchial-asthma group in the olfaction study is most accurate?
- The pediatric study found a positive correlation between lung function and olfactory performance in children with bronchial asthma. What does this result establish?
- Which combination correctly matches an atopic condition with the olfactory result reported in the pediatric study?
- A clinician asks whether olfactory testing can diagnose allergic rhinitis, atopic dermatitis, or asthma based on the prospective pediatric study. Which answer is best?
- Which overall statement best integrates the olfactory findings across pediatric atopic diseases in the prospective study?